CHAF1B and hepatocellular carcinoma: Consistent with these reports, our TCGA-LIHC analysis and institutional cohort data confirm CHAF1B overexpression in HCC, where it correlates with advanced TNM staging and reduced overall (OS) and relapse-free survival (RFS).